Oasis Tears Solution/ Drops
NDC 42126-6310
Product Information
Oasis Tears (glycerin) is a OTC MONOGRAPH DRUG-approved product labeled by Oasis Medical, Inc.. This product is used to relieve occasional constipation. It is supplied as a solution/ drops for ophthalmic administration. This product entry covers the primary NDC 42126-6310 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 42126-6310?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- GLYCERIN (UNII: PDC6A3C0OX) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYALURONATE SODIUM (UNII: YSE9PPT4TH)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW)
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)
- POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 998232 - glycerin 0.2 % Ophthalmic Solution
- RxCUI: 998232 - glycerin 2 MG/ML Ophthalmic Solution
- RxCUI: 998236 - Oasis Tears Plus 0.2 % Ophthalmic Solution
- RxCUI: 998236 - glycerin 2 MG/ML Ophthalmic Solution [Oasis Tears]
- RxCUI: 998236 - Oasis Tears 0.2 % Ophthalmic Drops
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.